Humana (NYSE:HUM) Price Target Raised to $220.00 at Truist Financial

Humana (NYSE:HUM) had its price objective hoisted by Truist Financial from $200.00 to $220.00 in a report released on Monday, MarketBeat Ratings reports. The firm currently has a hold rating on the insurance provider’s stock.

A number of other equities analysts also recently weighed in on HUM. Barclays decreased their target price on shares of Humana from $245.00 to $176.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 24th. Evercore upped their price target on Humana from $180.00 to $195.00 in a research note on Wednesday, April 8th. Morgan Stanley set a $146.00 price objective on Humana in a research report on Thursday, February 12th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Thursday, January 22nd. Finally, UBS Group reissued a “neutral” rating on shares of Humana in a report on Wednesday, February 25th. Seven research analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus price target of $224.65.

Humana Stock Performance

Shares of HUM stock opened at $198.18 on Monday. The company’s fifty day moving average price is $180.77 and its 200-day moving average price is $232.18. The stock has a market cap of $23.79 billion, a PE ratio of 20.18, a price-to-earnings-growth ratio of 2.06 and a beta of 0.44. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. Humana has a 12 month low of $163.11 and a 12 month high of $315.35.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company had revenue of $32.64 billion during the quarter, compared to analyst estimates of $32.08 billion. During the same period last year, the business earned ($2.16) EPS. Humana’s quarterly revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, equities analysts expect that Humana will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.8%. Humana’s dividend payout ratio (DPR) is 36.05%.

Insiders Place Their Bets

In other Humana news, insider Sanjay K. Shetty acquired 810 shares of the stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average cost of $185.21 per share, with a total value of $150,020.10. Following the transaction, the insider owned 11,657 shares of the company’s stock, valued at $2,158,992.97. The trade was a 7.47% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Montag A & Associates Inc. boosted its position in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the last quarter. CoreCap Advisors LLC raised its position in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new position in Humana in the 4th quarter worth about $27,000. Reflection Asset Management bought a new position in Humana during the 4th quarter valued at about $29,000. Finally, Rosenberg Matthew Hamilton lifted its stake in Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.